Commentary: Baseline adiponectin concentration and clinical outcomes among patients with diabetes and recent acute coronary syndrome in the EXAMINE trial

Front Endocrinol (Lausanne). 2018 Apr 3:9:138. doi: 10.3389/fendo.2018.00138. eCollection 2018.

Authors

Jan Brož¹, Marek Brabec^{2

3}, Milan Kvapil¹, Jan Polák⁴

Affiliations

¹ Department of Internal Medicine, Second Faculty of Medicine, Charles University, Prague, Czechia.
² Institute of Computer Science, The Czech Academy of Sciences, Prague, Czechia.
³ Czech Institute of Informatics, Robotics, and Cybernetics, Czech Technical University in Prague, Prague, Czechia.
⁴ Department for the Study of Obesity and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czechia.

No abstract available

Keywords: acute coronary syndrome; adiponectin; all-cause mortality rate; cardiovascular risk; type 2 diabetes mellitus.

Publication types

Comment